Niagen Bioscience (NAGE) Income from Non-Controlling Interests (2019 - 2020)
Niagen Bioscience's (NAGE) quarterly Income from Non-Controlling Interests came in at $3000.0 in Q2 2020, down 70.0% year-on-year from $10000.0 in Q3 2019, and down 70.0% on a QoQ basis from $10000.0 in Q2 2019.
Niagen Bioscience (NAGE) Income from Non-Controlling Interests (2019 - 2020) Analysis & Trends
Niagen Bioscience (NAGE) has 2 years of Income from Non-Controlling Interests data on file, last reported at $3000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | - |
| 10 | Niagen Bioscience | 256.89 Mn | 190.34 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2019 | 10,000.00 |